Section 475A.230 - Duties of Oregon Psilocybin Advisory Board The Oregon Psilocybin Advisory Board shall:
(1) Provide advice to the Oregon Health Authority with respect to the administration of ORS 475A.210 to 475A.722;(2) Make recommendations to the authority on available medical, psychological, and scientific studies, research, and other information relating to the safety and efficacy of psilocybin in treating mental health conditions, including but not limited to addiction, depression, anxiety disorders, and end-of-life psychological distress;(3) Make recommendations to the authority on the requirements, specifications and guidelines for providing psilocybin services to a client, including: (a) The requirements, specifications and guidelines for holding and verifying the completion of a preparation session, an administration session, and an integration session; and(b) The contents of the client information form that a client must complete and sign before the client participates in an administration session, giving particular consideration to: (A) The information that should be solicited from the client to determine whether the client should participate in the administration session, including information that may identify risk factors and contraindications;(B) The information that should be solicited from the client to assist the psilocybin service center operator and the psilocybin service facilitator in meeting any public health and safety standards and industry best practices during the administration session; and(C) The health and safety warnings and other disclosures that should be made to the client before the client participates in the administration session;(4) Make recommendations to the authority on public health and safety standards and industry best practices for each type of licensee under ORS 475A.210 to 475A.722;(5) Make recommendations to the authority on the formulation of a code of professional conduct for psilocybin service facilitators, giving particular consideration to a code of ethics;(6) Make recommendations to the authority on the education and training that psilocybin service facilitators must complete:(a) Giving particular consideration to:(A) Facilitation skills that are affirming, nonjudgmental, and nondirective;(B) Support skills for clients during an administration session, including specialized skills for: (ii) Clients who may have a mental health condition;(C) The environment in which psilocybin services should occur; and(D) Social and cultural considerations; and(b) Including whether such education and training should be available through online resources;(7) Make recommendations to the authority on the examinations that psilocybin service facilitators must pass;(8) Make recommendations to the authority on public health and safety standards and industry best practices for holding and completing an administration session, including:(a) Whether group administration sessions should be available;(b) Whether clients should be able to access common or outside areas on the premises of the psilocybin service center at which the administration session is held;(c) The circumstances under which an administration session is considered complete; and(d) The transportation needs of the client after the completion of the administration session;(9) Develop a long-term strategic plan for ensuring that psilocybin services will become and remain a safe, accessible and affordable therapeutic option for all persons 21 years of age and older in this state for whom psilocybin may be appropriate;(10) Monitor and study federal laws, regulations and policies regarding psilocybin; and(11) Attempt to meet with the United States Attorney's Office for the District of Oregon to discuss chapter 1, Oregon Laws 2021, and potential federal enforcement policies regarding psilocybin in Oregon after the expiration of the two-year program development period. Legislative Counsel has substituted "chapter 1, Oregon Laws 2021," for the words "this 2020 Act" in section 7, chapter 1, Oregon Laws 2021, compiled as 475A.230. Specific ORS references have not been substituted, pursuant to 173.160. The sections for which substitution otherwise would be made may be determined by referring to the 2021 Comparative Section Table located in Volume 22 of ORS.